nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—ABCB1—colon cancer	0.406	1	CbGaD
Nisoldipine—CYP3A7—Irinotecan—colon cancer	0.0604	0.135	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0604	0.135	CbGbCtD
Nisoldipine—CYP3A7—Vincristine—colon cancer	0.0528	0.118	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0528	0.118	CbGbCtD
Nisoldipine—CYP3A5—Irinotecan—colon cancer	0.0453	0.101	CbGbCtD
Nisoldipine—CYP3A5—Vincristine—colon cancer	0.0396	0.0885	CbGbCtD
Nisoldipine—CYP1A2—Fluorouracil—colon cancer	0.0324	0.0723	CbGbCtD
Nisoldipine—ABCB1—Irinotecan—colon cancer	0.0295	0.0659	CbGbCtD
Nisoldipine—ABCB1—Vincristine—colon cancer	0.0258	0.0576	CbGbCtD
Nisoldipine—CYP3A4—Irinotecan—colon cancer	0.0177	0.0395	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—colon cancer	0.0156	0.0349	CbGbCtD
Nisoldipine—CYP3A4—Vincristine—colon cancer	0.0154	0.0345	CbGbCtD
Nisoldipine—Weight decreased—Vincristine—colon cancer	0.000599	0.00442	CcSEcCtD
Nisoldipine—Mental disability—Capecitabine—colon cancer	0.000597	0.0044	CcSEcCtD
Nisoldipine—Ear pain—Capecitabine—colon cancer	0.000585	0.00432	CcSEcCtD
Nisoldipine—Weight decreased—Irinotecan—colon cancer	0.000583	0.0043	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Vincristine—colon cancer	0.000582	0.00429	CcSEcCtD
Nisoldipine—Myocardial infarction—Vincristine—colon cancer	0.000579	0.00427	CcSEcCtD
Nisoldipine—Stomatitis—Vincristine—colon cancer	0.000575	0.00425	CcSEcCtD
Nisoldipine—Diabetes mellitus—Capecitabine—colon cancer	0.000574	0.00424	CcSEcCtD
Nisoldipine—Skin discolouration—Methotrexate—colon cancer	0.000567	0.00418	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Irinotecan—colon cancer	0.000567	0.00418	CcSEcCtD
Nisoldipine—Sweating—Vincristine—colon cancer	0.000566	0.00418	CcSEcCtD
Nisoldipine—Myocardial infarction—Irinotecan—colon cancer	0.000563	0.00416	CcSEcCtD
Nisoldipine—Stomatitis—Irinotecan—colon cancer	0.00056	0.00413	CcSEcCtD
Nisoldipine—Herpes simplex—Methotrexate—colon cancer	0.000556	0.0041	CcSEcCtD
Nisoldipine—Glossitis—Methotrexate—colon cancer	0.000556	0.0041	CcSEcCtD
Nisoldipine—Sweating—Irinotecan—colon cancer	0.000551	0.00407	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000543	0.004	CcSEcCtD
Nisoldipine—Myocardial infarction—Fluorouracil—colon cancer	0.00054	0.00398	CcSEcCtD
Nisoldipine—Libido decreased—Capecitabine—colon cancer	0.000538	0.00397	CcSEcCtD
Nisoldipine—Stomatitis—Fluorouracil—colon cancer	0.000537	0.00396	CcSEcCtD
Nisoldipine—Conjunctivitis—Fluorouracil—colon cancer	0.000535	0.00395	CcSEcCtD
Nisoldipine—Increased appetite—Capecitabine—colon cancer	0.000531	0.00392	CcSEcCtD
Nisoldipine—Amnesia—Capecitabine—colon cancer	0.000531	0.00392	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Capecitabine—colon cancer	0.000529	0.0039	CcSEcCtD
Nisoldipine—Hypoaesthesia—Vincristine—colon cancer	0.000527	0.00389	CcSEcCtD
Nisoldipine—Atrial fibrillation—Capecitabine—colon cancer	0.000527	0.00389	CcSEcCtD
Nisoldipine—Epistaxis—Fluorouracil—colon cancer	0.000519	0.00383	CcSEcCtD
Nisoldipine—Rhinitis—Irinotecan—colon cancer	0.000517	0.00382	CcSEcCtD
Nisoldipine—Sinusitis—Fluorouracil—colon cancer	0.000517	0.00381	CcSEcCtD
Nisoldipine—Arthritis—Capecitabine—colon cancer	0.000514	0.00379	CcSEcCtD
Nisoldipine—Vaginal inflammation—Methotrexate—colon cancer	0.000512	0.00378	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Capecitabine—colon cancer	0.000509	0.00376	CcSEcCtD
Nisoldipine—CACNA1C—smooth muscle tissue—colon cancer	0.000504	0.0568	CbGeAlD
Nisoldipine—Melaena—Methotrexate—colon cancer	0.0005	0.00369	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000499	0.00368	CcSEcCtD
Nisoldipine—Visual impairment—Irinotecan—colon cancer	0.000497	0.00367	CcSEcCtD
Nisoldipine—Rhinitis—Fluorouracil—colon cancer	0.000495	0.00366	CcSEcCtD
Nisoldipine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000495	0.00365	CcSEcCtD
Nisoldipine—CACNB2—digestive system—colon cancer	0.000493	0.0556	CbGeAlD
Nisoldipine—Hypoaesthesia—Fluorouracil—colon cancer	0.000492	0.00363	CcSEcCtD
Nisoldipine—Migraine—Capecitabine—colon cancer	0.000491	0.00363	CcSEcCtD
Nisoldipine—Pharyngitis—Fluorouracil—colon cancer	0.000491	0.00362	CcSEcCtD
Nisoldipine—Vaginal infection—Methotrexate—colon cancer	0.000483	0.00357	CcSEcCtD
Nisoldipine—Face oedema—Capecitabine—colon cancer	0.000482	0.00356	CcSEcCtD
Nisoldipine—Ataxia—Capecitabine—colon cancer	0.000469	0.00346	CcSEcCtD
Nisoldipine—Alopecia—Vincristine—colon cancer	0.000468	0.00346	CcSEcCtD
Nisoldipine—Chills—Irinotecan—colon cancer	0.000463	0.00342	CcSEcCtD
Nisoldipine—Ecchymosis—Methotrexate—colon cancer	0.000463	0.00342	CcSEcCtD
Nisoldipine—Mouth ulceration—Methotrexate—colon cancer	0.000463	0.00342	CcSEcCtD
Nisoldipine—Liver function test abnormal—Capecitabine—colon cancer	0.000461	0.0034	CcSEcCtD
Nisoldipine—Gynaecomastia—Methotrexate—colon cancer	0.000458	0.00338	CcSEcCtD
Nisoldipine—Dry skin—Capecitabine—colon cancer	0.000458	0.00338	CcSEcCtD
Nisoldipine—Alopecia—Irinotecan—colon cancer	0.000456	0.00336	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Capecitabine—colon cancer	0.000456	0.00336	CcSEcCtD
Nisoldipine—Hypokalaemia—Capecitabine—colon cancer	0.000454	0.00335	CcSEcCtD
Nisoldipine—Flatulence—Irinotecan—colon cancer	0.000443	0.00327	CcSEcCtD
Nisoldipine—Gastritis—Capecitabine—colon cancer	0.000442	0.00326	CcSEcCtD
Nisoldipine—Muscular weakness—Capecitabine—colon cancer	0.00044	0.00325	CcSEcCtD
Nisoldipine—Alopecia—Fluorouracil—colon cancer	0.000437	0.00322	CcSEcCtD
Nisoldipine—CACNB2—vagina—colon cancer	0.000435	0.0491	CbGeAlD
Nisoldipine—Muscle spasms—Irinotecan—colon cancer	0.000432	0.00319	CcSEcCtD
Nisoldipine—Dysphagia—Capecitabine—colon cancer	0.000431	0.00318	CcSEcCtD
Nisoldipine—Influenza—Capecitabine—colon cancer	0.000431	0.00318	CcSEcCtD
Nisoldipine—Asthma—Capecitabine—colon cancer	0.000431	0.00318	CcSEcCtD
Nisoldipine—Diabetes mellitus—Methotrexate—colon cancer	0.000427	0.00315	CcSEcCtD
Nisoldipine—CACNA2D1—bone marrow—colon cancer	0.000427	0.0481	CbGeAlD
Nisoldipine—Anaemia—Vincristine—colon cancer	0.000426	0.00315	CcSEcCtD
Nisoldipine—Ill-defined disorder—Irinotecan—colon cancer	0.000417	0.00308	CcSEcCtD
Nisoldipine—Anaemia—Irinotecan—colon cancer	0.000415	0.00306	CcSEcCtD
Nisoldipine—Vertigo—Vincristine—colon cancer	0.000414	0.00306	CcSEcCtD
Nisoldipine—CYP3A7—liver—colon cancer	0.000414	0.0467	CbGeAlD
Nisoldipine—Leukopenia—Vincristine—colon cancer	0.000413	0.00305	CcSEcCtD
Nisoldipine—CACNA2D1—vagina—colon cancer	0.000409	0.0461	CbGeAlD
Nisoldipine—Malaise—Irinotecan—colon cancer	0.000405	0.00299	CcSEcCtD
Nisoldipine—Vertigo—Irinotecan—colon cancer	0.000404	0.00298	CcSEcCtD
Nisoldipine—Dysuria—Capecitabine—colon cancer	0.000403	0.00298	CcSEcCtD
Nisoldipine—Syncope—Irinotecan—colon cancer	0.000403	0.00297	CcSEcCtD
Nisoldipine—Leukopenia—Irinotecan—colon cancer	0.000402	0.00297	CcSEcCtD
Nisoldipine—CACNA1C—digestive system—colon cancer	0.000398	0.0448	CbGeAlD
Nisoldipine—Anaemia—Fluorouracil—colon cancer	0.000398	0.00293	CcSEcCtD
Nisoldipine—Loss of consciousness—Irinotecan—colon cancer	0.000395	0.00291	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Methotrexate—colon cancer	0.000394	0.00291	CcSEcCtD
Nisoldipine—Myalgia—Vincristine—colon cancer	0.000393	0.0029	CcSEcCtD
Nisoldipine—Weight increased—Capecitabine—colon cancer	0.000393	0.0029	CcSEcCtD
Nisoldipine—Cough—Irinotecan—colon cancer	0.000392	0.00289	CcSEcCtD
Nisoldipine—Weight decreased—Capecitabine—colon cancer	0.00039	0.00288	CcSEcCtD
Nisoldipine—Leukopenia—Fluorouracil—colon cancer	0.000385	0.00284	CcSEcCtD
Nisoldipine—Nitrendipine—ABCB1—colon cancer	0.000383	0.239	CrCbGaD
Nisoldipine—Acute coronary syndrome—Capecitabine—colon cancer	0.000379	0.0028	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Methotrexate—colon cancer	0.000379	0.0028	CcSEcCtD
Nisoldipine—Discomfort—Irinotecan—colon cancer	0.000378	0.00279	CcSEcCtD
Nisoldipine—Myocardial infarction—Capecitabine—colon cancer	0.000377	0.00278	CcSEcCtD
Nisoldipine—Oedema—Vincristine—colon cancer	0.000376	0.00278	CcSEcCtD
Nisoldipine—Stomatitis—Capecitabine—colon cancer	0.000375	0.00277	CcSEcCtD
Nisoldipine—Conjunctivitis—Capecitabine—colon cancer	0.000374	0.00276	CcSEcCtD
Nisoldipine—Confusional state—Irinotecan—colon cancer	0.00037	0.00273	CcSEcCtD
Nisoldipine—CACNB2—liver—colon cancer	0.000367	0.0414	CbGeAlD
Nisoldipine—Haematuria—Capecitabine—colon cancer	0.000367	0.00271	CcSEcCtD
Nisoldipine—Oedema—Irinotecan—colon cancer	0.000367	0.00271	CcSEcCtD
Nisoldipine—Chest pain—Fluorouracil—colon cancer	0.000366	0.0027	CcSEcCtD
Nisoldipine—Myalgia—Fluorouracil—colon cancer	0.000366	0.0027	CcSEcCtD
Nisoldipine—Hyperhidrosis—Vincristine—colon cancer	0.000364	0.00269	CcSEcCtD
Nisoldipine—Epistaxis—Capecitabine—colon cancer	0.000363	0.00268	CcSEcCtD
Nisoldipine—Discomfort—Fluorouracil—colon cancer	0.000362	0.00267	CcSEcCtD
Nisoldipine—Shock—Irinotecan—colon cancer	0.000361	0.00266	CcSEcCtD
Nisoldipine—Anorexia—Vincristine—colon cancer	0.000359	0.00265	CcSEcCtD
Nisoldipine—Hyperhidrosis—Irinotecan—colon cancer	0.000354	0.00262	CcSEcCtD
Nisoldipine—Confusional state—Fluorouracil—colon cancer	0.000354	0.00261	CcSEcCtD
Nisoldipine—CYP3A7-CYP3A51P—liver—colon cancer	0.000352	0.0397	CbGeAlD
Nisoldipine—Hypotension—Vincristine—colon cancer	0.000352	0.0026	CcSEcCtD
Nisoldipine—CACNA1C—vagina—colon cancer	0.000351	0.0396	CbGeAlD
Nisoldipine—Oedema—Fluorouracil—colon cancer	0.000351	0.00259	CcSEcCtD
Nisoldipine—Anorexia—Irinotecan—colon cancer	0.000349	0.00258	CcSEcCtD
Nisoldipine—Ataxia—Methotrexate—colon cancer	0.000349	0.00258	CcSEcCtD
Nisoldipine—Rhinitis—Capecitabine—colon cancer	0.000346	0.00255	CcSEcCtD
Nisoldipine—CACNA2D1—liver—colon cancer	0.000345	0.0389	CbGeAlD
Nisoldipine—Hypoaesthesia—Capecitabine—colon cancer	0.000344	0.00254	CcSEcCtD
Nisoldipine—Liver function test abnormal—Methotrexate—colon cancer	0.000343	0.00253	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000343	0.00253	CcSEcCtD
Nisoldipine—Pharyngitis—Capecitabine—colon cancer	0.000343	0.00253	CcSEcCtD
Nisoldipine—Tachycardia—Fluorouracil—colon cancer	0.000343	0.00253	CcSEcCtD
Nisoldipine—Hypotension—Irinotecan—colon cancer	0.000343	0.00253	CcSEcCtD
Nisoldipine—Insomnia—Vincristine—colon cancer	0.00034	0.00251	CcSEcCtD
Nisoldipine—Oedema peripheral—Capecitabine—colon cancer	0.00034	0.00251	CcSEcCtD
Nisoldipine—Paraesthesia—Vincristine—colon cancer	0.000338	0.00249	CcSEcCtD
Nisoldipine—Anorexia—Fluorouracil—colon cancer	0.000335	0.00247	CcSEcCtD
Nisoldipine—Visual impairment—Capecitabine—colon cancer	0.000333	0.00246	CcSEcCtD
Nisoldipine—Insomnia—Irinotecan—colon cancer	0.000332	0.00245	CcSEcCtD
Nisoldipine—Amlodipine—ABCB1—colon cancer	0.00033	0.206	CrCbGaD
Nisoldipine—Paraesthesia—Irinotecan—colon cancer	0.000329	0.00243	CcSEcCtD
Nisoldipine—Hypotension—Fluorouracil—colon cancer	0.000328	0.00242	CcSEcCtD
Nisoldipine—Decreased appetite—Vincristine—colon cancer	0.000327	0.00241	CcSEcCtD
Nisoldipine—Dyspnoea—Irinotecan—colon cancer	0.000327	0.00241	CcSEcCtD
Nisoldipine—Somnolence—Irinotecan—colon cancer	0.000326	0.0024	CcSEcCtD
Nisoldipine—Dyspepsia—Irinotecan—colon cancer	0.000323	0.00238	CcSEcCtD
Nisoldipine—Tinnitus—Capecitabine—colon cancer	0.000322	0.00238	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—colon cancer	0.000321	0.00237	CcSEcCtD
Nisoldipine—CACNA1D—liver—colon cancer	0.000321	0.0362	CbGeAlD
Nisoldipine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00032	0.00236	CcSEcCtD
Nisoldipine—Decreased appetite—Irinotecan—colon cancer	0.000319	0.00235	CcSEcCtD
Nisoldipine—Insomnia—Fluorouracil—colon cancer	0.000318	0.00234	CcSEcCtD
Nisoldipine—Paraesthesia—Fluorouracil—colon cancer	0.000315	0.00233	CcSEcCtD
Nisoldipine—Dyspnoea—Fluorouracil—colon cancer	0.000313	0.00231	CcSEcCtD
Nisoldipine—Somnolence—Fluorouracil—colon cancer	0.000312	0.0023	CcSEcCtD
Nisoldipine—Chills—Capecitabine—colon cancer	0.00031	0.00229	CcSEcCtD
Nisoldipine—Dyspepsia—Fluorouracil—colon cancer	0.000309	0.00228	CcSEcCtD
Nisoldipine—Decreased appetite—Fluorouracil—colon cancer	0.000305	0.00225	CcSEcCtD
Nisoldipine—Alopecia—Capecitabine—colon cancer	0.000305	0.00225	CcSEcCtD
Nisoldipine—Felodipine—ABCB1—colon cancer	0.000305	0.19	CrCbGaD
Nisoldipine—Feeling abnormal—Irinotecan—colon cancer	0.000302	0.00223	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—colon cancer	0.0003	0.00222	CcSEcCtD
Nisoldipine—Body temperature increased—Vincristine—colon cancer	0.000298	0.0022	CcSEcCtD
Nisoldipine—Flatulence—Capecitabine—colon cancer	0.000296	0.00219	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—colon cancer	0.000296	0.00218	CcSEcCtD
Nisoldipine—Nifedipine—ABCB1—colon cancer	0.000295	0.184	CrCbGaD
Nisoldipine—Dysgeusia—Capecitabine—colon cancer	0.000294	0.00217	CcSEcCtD
Nisoldipine—Nicardipine—ABCB1—colon cancer	0.00029	0.181	CrCbGaD
Nisoldipine—Body temperature increased—Irinotecan—colon cancer	0.00029	0.00214	CcSEcCtD
Nisoldipine—Feeling abnormal—Fluorouracil—colon cancer	0.000289	0.00214	CcSEcCtD
Nisoldipine—Muscle spasms—Capecitabine—colon cancer	0.000289	0.00213	CcSEcCtD
Nisoldipine—Tremor—Capecitabine—colon cancer	0.000282	0.00208	CcSEcCtD
Nisoldipine—CACNB2—lymph node—colon cancer	0.000282	0.0317	CbGeAlD
Nisoldipine—ABCB1—blood vessel—colon cancer	0.000281	0.0316	CbGeAlD
Nisoldipine—Stomatitis—Methotrexate—colon cancer	0.000279	0.00206	CcSEcCtD
Nisoldipine—Ill-defined disorder—Capecitabine—colon cancer	0.000279	0.00206	CcSEcCtD
Nisoldipine—Urticaria—Fluorouracil—colon cancer	0.000279	0.00206	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—colon cancer	0.000278	0.00205	CcSEcCtD
Nisoldipine—Anaemia—Capecitabine—colon cancer	0.000278	0.00205	CcSEcCtD
Nisoldipine—Body temperature increased—Fluorouracil—colon cancer	0.000278	0.00205	CcSEcCtD
Nisoldipine—Hypersensitivity—Vincristine—colon cancer	0.000277	0.00205	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—colon cancer	0.000275	0.00203	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—colon cancer	0.000273	0.00201	CcSEcCtD
Nisoldipine—Malaise—Capecitabine—colon cancer	0.000271	0.002	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—colon cancer	0.00027	0.00199	CcSEcCtD
Nisoldipine—Vertigo—Capecitabine—colon cancer	0.00027	0.00199	CcSEcCtD
Nisoldipine—Hypersensitivity—Irinotecan—colon cancer	0.00027	0.00199	CcSEcCtD
Nisoldipine—Syncope—Capecitabine—colon cancer	0.00027	0.00199	CcSEcCtD
Nisoldipine—Leukopenia—Capecitabine—colon cancer	0.000269	0.00199	CcSEcCtD
Nisoldipine—Palpitations—Capecitabine—colon cancer	0.000266	0.00196	CcSEcCtD
Nisoldipine—CACNA2D1—lymph node—colon cancer	0.000264	0.0298	CbGeAlD
Nisoldipine—Loss of consciousness—Capecitabine—colon cancer	0.000264	0.00195	CcSEcCtD
Nisoldipine—Cough—Capecitabine—colon cancer	0.000262	0.00194	CcSEcCtD
Nisoldipine—Hypersensitivity—Fluorouracil—colon cancer	0.000259	0.00191	CcSEcCtD
Nisoldipine—Diarrhoea—Vincristine—colon cancer	0.000258	0.0019	CcSEcCtD
Nisoldipine—Arthralgia—Capecitabine—colon cancer	0.000256	0.00189	CcSEcCtD
Nisoldipine—Chest pain—Capecitabine—colon cancer	0.000256	0.00189	CcSEcCtD
Nisoldipine—Myalgia—Capecitabine—colon cancer	0.000256	0.00189	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—colon cancer	0.000255	0.00188	CcSEcCtD
Nisoldipine—Anxiety—Capecitabine—colon cancer	0.000255	0.00188	CcSEcCtD
Nisoldipine—Discomfort—Capecitabine—colon cancer	0.000253	0.00187	CcSEcCtD
Nisoldipine—Diarrhoea—Irinotecan—colon cancer	0.000251	0.00185	CcSEcCtD
Nisoldipine—Dry mouth—Capecitabine—colon cancer	0.00025	0.00185	CcSEcCtD
Nisoldipine—Dizziness—Vincristine—colon cancer	0.000249	0.00184	CcSEcCtD
Nisoldipine—Pruritus—Fluorouracil—colon cancer	0.000248	0.00183	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—colon cancer	0.000248	0.00183	CcSEcCtD
Nisoldipine—CYP1A2—renal system—colon cancer	0.000247	0.0279	CbGeAlD
Nisoldipine—Confusional state—Capecitabine—colon cancer	0.000247	0.00183	CcSEcCtD
Nisoldipine—CACNA1D—lymph node—colon cancer	0.000246	0.0277	CbGeAlD
Nisoldipine—Oedema—Capecitabine—colon cancer	0.000245	0.00181	CcSEcCtD
Nisoldipine—Dizziness—Irinotecan—colon cancer	0.000242	0.00179	CcSEcCtD
Nisoldipine—Shock—Capecitabine—colon cancer	0.000241	0.00178	CcSEcCtD
Nisoldipine—Diarrhoea—Fluorouracil—colon cancer	0.00024	0.00177	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—colon cancer	0.00024	0.00177	CcSEcCtD
Nisoldipine—Tachycardia—Capecitabine—colon cancer	0.000239	0.00177	CcSEcCtD
Nisoldipine—CYP3A5—renal system—colon cancer	0.000239	0.0269	CbGeAlD
Nisoldipine—Rash—Vincristine—colon cancer	0.000237	0.00175	CcSEcCtD
Nisoldipine—Hyperhidrosis—Capecitabine—colon cancer	0.000237	0.00175	CcSEcCtD
Nisoldipine—Dermatitis—Vincristine—colon cancer	0.000237	0.00175	CcSEcCtD
Nisoldipine—Headache—Vincristine—colon cancer	0.000236	0.00174	CcSEcCtD
Nisoldipine—Anorexia—Capecitabine—colon cancer	0.000234	0.00173	CcSEcCtD
Nisoldipine—Dizziness—Fluorouracil—colon cancer	0.000232	0.00171	CcSEcCtD
Nisoldipine—Rash—Irinotecan—colon cancer	0.000231	0.00171	CcSEcCtD
Nisoldipine—Dermatitis—Irinotecan—colon cancer	0.000231	0.0017	CcSEcCtD
Nisoldipine—Chills—Methotrexate—colon cancer	0.000231	0.0017	CcSEcCtD
Nisoldipine—Headache—Irinotecan—colon cancer	0.00023	0.00169	CcSEcCtD
Nisoldipine—Hypotension—Capecitabine—colon cancer	0.000229	0.00169	CcSEcCtD
Nisoldipine—CACNA1C—lymph node—colon cancer	0.000227	0.0256	CbGeAlD
Nisoldipine—Alopecia—Methotrexate—colon cancer	0.000227	0.00168	CcSEcCtD
Nisoldipine—Nausea—Vincristine—colon cancer	0.000224	0.00165	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000224	0.00165	CcSEcCtD
Nisoldipine—Insomnia—Capecitabine—colon cancer	0.000222	0.00164	CcSEcCtD
Nisoldipine—Rash—Fluorouracil—colon cancer	0.000221	0.00163	CcSEcCtD
Nisoldipine—Dermatitis—Fluorouracil—colon cancer	0.000221	0.00163	CcSEcCtD
Nisoldipine—Paraesthesia—Capecitabine—colon cancer	0.00022	0.00163	CcSEcCtD
Nisoldipine—Headache—Fluorouracil—colon cancer	0.00022	0.00162	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—colon cancer	0.000219	0.00162	CcSEcCtD
Nisoldipine—Dyspnoea—Capecitabine—colon cancer	0.000219	0.00161	CcSEcCtD
Nisoldipine—Nausea—Irinotecan—colon cancer	0.000218	0.00161	CcSEcCtD
Nisoldipine—Dyspepsia—Capecitabine—colon cancer	0.000216	0.00159	CcSEcCtD
Nisoldipine—Decreased appetite—Capecitabine—colon cancer	0.000213	0.00157	CcSEcCtD
Nisoldipine—Nausea—Fluorouracil—colon cancer	0.000209	0.00154	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—colon cancer	0.000208	0.00153	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—colon cancer	0.000207	0.00153	CcSEcCtD
Nisoldipine—CYP1A2—digestive system—colon cancer	0.000203	0.0229	CbGeAlD
Nisoldipine—Feeling abnormal—Capecitabine—colon cancer	0.000202	0.00149	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—colon cancer	0.000202	0.00149	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—colon cancer	0.000201	0.00148	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—colon cancer	0.0002	0.00148	CcSEcCtD
Nisoldipine—CYP3A5—digestive system—colon cancer	0.000196	0.0221	CbGeAlD
Nisoldipine—Cough—Methotrexate—colon cancer	0.000195	0.00144	CcSEcCtD
Nisoldipine—Urticaria—Capecitabine—colon cancer	0.000195	0.00144	CcSEcCtD
Nisoldipine—Body temperature increased—Capecitabine—colon cancer	0.000194	0.00143	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—colon cancer	0.000191	0.00141	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—colon cancer	0.000191	0.00141	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—colon cancer	0.000191	0.00141	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—colon cancer	0.000188	0.00139	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—colon cancer	0.000184	0.00136	CcSEcCtD
Nisoldipine—Hypersensitivity—Capecitabine—colon cancer	0.000181	0.00133	CcSEcCtD
Nisoldipine—CYP3A4—renal system—colon cancer	0.000179	0.0202	CbGeAlD
Nisoldipine—Hyperhidrosis—Methotrexate—colon cancer	0.000177	0.0013	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—colon cancer	0.000174	0.00128	CcSEcCtD
Nisoldipine—Pruritus—Capecitabine—colon cancer	0.000174	0.00128	CcSEcCtD
Nisoldipine—CYP3A5—vagina—colon cancer	0.000173	0.0195	CbGeAlD
Nisoldipine—Hypotension—Methotrexate—colon cancer	0.000171	0.00126	CcSEcCtD
Nisoldipine—Diarrhoea—Capecitabine—colon cancer	0.000168	0.00124	CcSEcCtD
Nisoldipine—ABCB1—embryo—colon cancer	0.000167	0.0189	CbGeAlD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000166	0.00123	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—colon cancer	0.000165	0.00122	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—colon cancer	0.000164	0.00121	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—colon cancer	0.000163	0.0012	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—colon cancer	0.000162	0.0012	CcSEcCtD
Nisoldipine—Dizziness—Capecitabine—colon cancer	0.000162	0.0012	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—colon cancer	0.000161	0.00119	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—colon cancer	0.000159	0.00117	CcSEcCtD
Nisoldipine—Rash—Capecitabine—colon cancer	0.000155	0.00114	CcSEcCtD
Nisoldipine—Dermatitis—Capecitabine—colon cancer	0.000155	0.00114	CcSEcCtD
Nisoldipine—Headache—Capecitabine—colon cancer	0.000154	0.00113	CcSEcCtD
Nisoldipine—CYP1A2—liver—colon cancer	0.000151	0.017	CbGeAlD
Nisoldipine—Feeling abnormal—Methotrexate—colon cancer	0.000151	0.00111	CcSEcCtD
Nisoldipine—CYP3A4—digestive system—colon cancer	0.000147	0.0166	CbGeAlD
Nisoldipine—CYP3A5—liver—colon cancer	0.000146	0.0164	CbGeAlD
Nisoldipine—Nausea—Capecitabine—colon cancer	0.000146	0.00108	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—colon cancer	0.000145	0.00107	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—colon cancer	0.000144	0.00107	CcSEcCtD
Nisoldipine—ABCB1—epithelium—colon cancer	0.000137	0.0154	CbGeAlD
Nisoldipine—Hypersensitivity—Methotrexate—colon cancer	0.000135	0.000993	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—colon cancer	0.000129	0.000954	CcSEcCtD
Nisoldipine—ABCB1—renal system—colon cancer	0.000127	0.0143	CbGeAlD
Nisoldipine—Diarrhoea—Methotrexate—colon cancer	0.000125	0.000922	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—colon cancer	0.000121	0.000891	CcSEcCtD
Nisoldipine—Rash—Methotrexate—colon cancer	0.000115	0.00085	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—colon cancer	0.000115	0.000849	CcSEcCtD
Nisoldipine—Headache—Methotrexate—colon cancer	0.000114	0.000844	CcSEcCtD
Nisoldipine—CYP3A4—liver—colon cancer	0.000109	0.0123	CbGeAlD
Nisoldipine—Nausea—Methotrexate—colon cancer	0.000108	0.000801	CcSEcCtD
Nisoldipine—ABCB1—lymphoid tissue—colon cancer	0.000105	0.0119	CbGeAlD
Nisoldipine—ABCB1—digestive system—colon cancer	0.000104	0.0117	CbGeAlD
Nisoldipine—ABCB1—bone marrow—colon cancer	9.58e-05	0.0108	CbGeAlD
Nisoldipine—ABCB1—vagina—colon cancer	9.18e-05	0.0103	CbGeAlD
Nisoldipine—ABCB1—liver—colon cancer	7.75e-05	0.00873	CbGeAlD
Nisoldipine—ABCB1—lymph node—colon cancer	5.94e-05	0.00669	CbGeAlD
